Q4 2023 13F Holders as of 12/31/2023
-
Type / Class
-
Equity / Common Stock, $0.00001 par value
-
Shares outstanding
-
179M
-
Number of holders
-
1
-
Total 13F shares, excl. options
-
16.2K
-
Shares change
-
0
-
Total reported value, excl. options
-
$143K
-
Price
-
$8.86
Significant Holders of Prime Medicine, Inc. - Common Stock, $0.00001 par value (PRME) as of Q4 2023
1 filings reported holding PRME - Prime Medicine, Inc. - Common Stock, $0.00001 par value as of Q4 2023.
Prime Medicine, Inc. - Common Stock, $0.00001 par value (PRME) has 1 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 16.2K shares
of 179M outstanding shares and own 0.01% of the company stock.
Largest 10 shareholders include Alphabet Inc. (11.9M shares), VANGUARD GROUP INC (4.05M shares), FMR LLC (3.93M shares), BlackRock Inc. (3.78M shares), Nikko Asset Management Americas, Inc. (3.52M shares), Sumitomo Mitsui Trust Holdings, Inc. (3.52M shares), ARK Investment Management LLC (3.14M shares), PRICE T ROWE ASSOCIATES INC /MD/ (2.22M shares), MWG Management Ltd. (1.79M shares), and Redmile Group, LLC (1.32M shares).
This table shows the top 1 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.